Streetbeat News

Revenues

CSTL

Castle Biosciences highlights a study showing a 35% increase in medication response and a 64% increase in remission for patients whose medication management was guided by IDgenetix compared to those without guidance.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:05 am

RVLCF

Rivalry Corp. has launched its mobile app in Ontario, providing residents access to its next-generation betting platform for esports and traditional sports. Since acquiring its license in April 2022, Rivalry has experienced a 15% average month-over-month growth rate in esports betting. The company reported 1Q23 revenues of $12 million, a 151% YoY increase, and a betting handle of $120.2M, up 199% YoY.

Portfolio Pulse from Akanksha Bakshi

May 31, 2023 | 11:04 am

SHCR

Sharecare announced that it is on track to achieve its full-year 2023 revenue and adjusted EBITDA guidance. The digital health company's progress indicates a positive outlook for its financial performance.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:04 am

TRVN

Trevena, Inc. (NASDAQ:TRVN) has received a $3 million milestone payment from its Chinese partner, Jiangsu Nhwa Pharmaceutical, for the approval of OLINVYK in China.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:03 am

RSVR

Reservoir Media forecasts FY23 revenue of $127M - $132M, surpassing the estimated $121.21M.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 11:03 am

CD

Chindata Group Holdings reiterates its FY23 revenue guidance of $859.4M-$888.6M, in line with the consensus of $868.34M, and raises its adjusted EBITDA guidance to $453.1M-$470.6M, up from the previous $438.5M-$454.5M.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 10:40 am

AAP

Advance Auto Parts has reduced its FY23 revenue outlook from $11.4B-$11.6B to $11.2B-$11.3B, compared to the estimated $11.44B.

Portfolio Pulse from Benzinga Newsdesk

May 31, 2023 | 10:36 am

BRTX

BioRestorative Therapies (NASDAQ:BRTX) has obtained a license from the New York State Department of Health to act as a tissue bank for processing mesenchymal stem cells from autologous donors. This makes BioRestorative the first facility in New York State to be licensed for this purpose.

Portfolio Pulse from Anusuya Lahiri

May 31, 2023 | 10:31 am

AI

AMBA

HPE

TGT

TSLA

Investors are focusing on Tesla, C3.ai, Target, Ambarella, and Hewlett Packard stocks due to recent events. Tesla's Elon Musk visited China, C3.ai is set to report earnings, Target faces a boycott, Ambarella issued a weak Q2 forecast, and Hewlett Packard missed revenue estimates.

Portfolio Pulse from Bhavik Nair

May 31, 2023 | 1:16 am

MYCOF

Mydecine Innovations Group (OTC:MYCOF) has filed a shelf prospectus supplement for the distribution of up to 15,151,515 common shares at $0.24 per share, raising up to $3.68 million. The company recently developed a new set of MDMA analogs with positive preclinical trial outcomes. However, its Q1 2023 financial statements may raise concerns.

Portfolio Pulse from Lara Goldstein

May 31, 2023 | 12:30 am